Funded Tech Companies
RVAC Medicines
Headquartered in Shanghai, RVAC Medicines raised its funding from Edbi, CBC Capital and Pavilion Capital Partners.
Company Overview
Company Name
RVAC Medicines
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
Unit 2601 & 2611-12, CITIC Square No.1168 West Nanjing Road,
Shanghai, 200041
China
Shanghai, 200041
China
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
RVAC Medicines is an mRNA platform company. We are building a diverse pipeline of innovative medicines. Our leading asset, a COVID-19 vaccine, is quickly moving into clinical trials and is well-positioned to serve emerging markets in regions that are struggling with vaccine access, where we are rapidly establishing regional manufacture capabilities. Our company has built its team with top-tier scientists and established key partnerships to leverage clinically validated technologies. Incubated by the CBC Group, RVAC Medicines is headquartered in Singapore with R&D centers in Boston and Shanghai.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
4/26/2022
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Sean Fu
Chief Medical Officer
Roberto Guerciolini
Chief Scientific Officer
Jason Zhang
Company Investors
- Edbi
- CBC Capital
- Pavilion Capital Partners
- GS Holdings
Browse more funded tech companies:
Ruxton Pharmaceuticals | RVH Solutions
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading supplier of venture capital funding data.
Additional Resources for Entrepreneurs